TargetReceptor-type tyrosine-protein phosphatase C(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 280nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of CD45More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 1.82E+4nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of PTP1BMore data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 3.02E+4nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of PP2AMore data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 3.08E+4nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of PP1More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase C(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 3.42E+4nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of CD45More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 3.81E+4nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of PTP-S2More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 5.52E+4nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of PTP-S2More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 5.54E+4nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of PP1More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase C(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 8.05E+4nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of CD45More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase C(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 1.20E+5nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of CD45More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase C(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 3.80E+5nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of CD45More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: >1.00E+6nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of PTP1BMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase C(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: >1.00E+6nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of CD45More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: >1.00E+6nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of PP2AMore data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: >1.00E+6nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of LARMore data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1(Homo sapiens (Human))
Taisho Pharmaceutical
Curated by ChEMBL
Taisho Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: >1.00E+6nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of LARMore data for this Ligand-Target Pair